Theravance Biopharma, Inc. (TBPH)

Altus Power Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	110.61	37.8	39.55	298.17	89.96	81.47
Short-Term Investments	20.24	50.55	62.88	29.31	83.51	211.47
Cash & Short-Term Investments	130.86	88.35	102.43	327.48	173.47	292.94
Cash Growth	30.89%	-13.74%	-68.72%	88.79%	-40.78%	4.31%
Accounts Receivable	15.35	18.44	17.47	16.79	14.07	15.87
Other Receivables	-	50	-	-	-	53.8
Receivables	15.35	68.44	17.47	16.79	14.07	69.67
Prepaid Expenses	4.06	4.28	13.64	9.2	18.81	30.73
Other Current Assets	-	-	-	-	43.53	-
Total Current Assets	150.26	161.07	133.54	353.46	249.87	393.34
Property, Plant & Equipment	34.46	35.77	45.36	52	53.35	59.68
Long-Term Investments	-	-	-	-	-	12.75
Other Long-Term Assets	158.86	157.32	203.1	201.94	71.6	3.28
Total Assets	343.58	354.16	382	607.4	374.82	469.06
Accounts Payable	2.41	2.24	1.52	1.55	3.1	6.78
Accrued Expenses	12.43	13.28	12.83	20.41	37.95	76.07
Current Portion of Long-Term Debt	-	-	-	-	16.94	19.33
Current Portion of Leases	10.81	10.71	3.92	6.75	0.5	9.87
Current Income Taxes Payable	5.85	5.85	-	-	-	-
Current Unearned Revenue	-	-	-	-	0.1	11.52
Other Current Liabilities	-	-	6.49	-	-	-
Total Current Liabilities	31.5	32.09	24.77	28.72	58.59	123.57
Long-Term Debt	-	-	-	-	599.39	599.84
Long-Term Leases	37.35	39.11	45.24	45.41	52.68	47.22
Long-Term Unearned Revenue	-	-	-	0.19	0.31	0.35
Other Long-Term Liabilities	108.75	107.42	99	91.29	2.42	1.83
Total Liabilities	177.6	178.62	169	165.6	713.39	772.81
Common Stock	0	-	-	0	0	0
Additional Paid-In Capital	1,145	1,141	1,122	1,296	1,387	1,223
Retained Earnings	-979.1	-965.52	-909.1	-853.91	-1,726	-1,527
Comprehensive Income & Other	-	0.01	-0.07	-0.02	-	0.05
Shareholders' Equity	165.98	175.55	213	441.8	-338.57	-303.75
Total Liabilities & Equity	343.58	354.16	382	607.4	374.82	469.06
Total Debt	48.16	49.82	49.16	52.16	669.52	676.26
Net Cash (Debt)	82.7	38.53	53.27	275.32	-496.05	-383.32
Net Cash Growth	58.82%	-27.67%	-80.65%	-	-	-
Net Cash Per Share	1.68	0.79	0.96	3.74	-7.14	-6.15
Filing Date Shares Outstanding	50	49.47	48.16	62.86	74.7	64.33
Total Common Shares Outstanding	50	49.47	48.09	65.23	74.44	64.33
Working Capital	118.76	128.98	108.77	324.75	191.28	269.77
Book Value Per Share	3.32	3.55	4.43	6.77	-4.55	-4.72
Tangible Book Value	165.98	175.55	213	441.8	-338.57	-303.75
Tangible Book Value Per Share	3.32	3.55	4.43	6.77	-4.55	-4.72
Machinery	-	3.74	3.68	19.04	26.03	35.88
Leasehold Improvements	-	25.32	26.21	24.58	24.05	24.28

Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q